¶ Hypercortisolaemia
¶ Definition
Hypercortisolaemia is a state of chronically elevated Cortisol levels (typically >20 μg/dL morning serum) persisting beyond adaptive stress responses. This becomes pathological when Glucocorticoid Receptor (GR) downregulation occurs, transforming Cortisol from an anti-inflammatory regulator into a neurotoxic and pro-inflammatory agent. The condition represents a failure of Allostasis, where the body's attempt to maintain stability through elevated Cortisol creates systemic damage instead.
¶ Picture It
Think of cortisol as a fire department's water supply. In acute stress (a house fire), high-pressure water (cortisol) effectively puts out flames (inflammation). But imagine the water main stays pressurized for months—eventually, homeowners install smaller pipes and pressure regulators (receptor downregulation) to protect their plumbing. Now when a fire breaks out, the high-pressure water can't reach it because the connection points are shut down. Worse, the constant pressure damages foundations (neurons), floods basements (metabolic dysfunction), and even ignites electrical fires (paradoxical inflammation) because safety systems are overwhelmed. The fire department keeps pumping more water (more cortisol production), but without functional hoses (receptors), the water just causes more damage. This is hypercortisolaemia: a rescue signal that's been on too long becomes the problem itself.
¶ Mechanism
Chronic activation of the HPA axis initiates the cascade:
Phase 1 — Sustained Cortisol Production:
Hypothalamus → CRH release → anterior pituitary → ACTH → adrenal cortex → sustained Cortisol synthesis (>15-20 μg/dL across multiple timepoints)
Phase 2 — Receptor Downregulation:
Chronically elevated Cortisol → GR gene (NR3C1) methylation via DNA Methylation → reduced GR expression in:
- Hippocampus neurons (particularly CA1 and CA3 regions)
- Hypothalamus (paraventricular nucleus)
- Leukocytes (monocytes, T cells)
- Hepatocytes and adipocytes
Phase 3 — Loss of Negative Feedback:
Reduced hippocampal GR → impaired negative feedback on CRH/ACTH → further Cortisol elevation → self-perpetuating cycle
Phase 4 — Neurotoxicity Cascade:
High Cortisol without functional GR →
- Excessive Glutamate release → NMDA receptor overactivation → Ca²⁺ influx → mitochondrial dysfunction → neuronal apoptosis
- Reduced BDNF expression → impaired Adult Hippocampal Neurogenesis
- Increased Reactive Oxygen Species production → oxidative damage to hippocampal dendrites
- Measurable as hippocampal atrophy on MRI (volume reduction 10-20% in chronic cases)
Phase 5 — Immune Paradox:
Cortisol resistance in immune cells:
- Monocytes maintain NF-κB activity despite high Cortisol
- SOCS1 and SOCS3 upregulation blocks GR signaling
- Result: elevated IL-6 (>10 pg/mL), TNF-α (>8 pg/mL), CRP (>3 mg/L) coexist with high Cortisol
- The "Conserved Transcriptional Response to Adversity" profile emerges
¶ Clinical Significance
Hypercortisolaemia is central to understanding why chronic stress produces the paradox of immune activation despite high glucocorticoid levels—a cornerstone of cPNI clinical reasoning.
Key Patient Populations:
- Depression with melancholic features (40-60% show hypercortisolaemia)
- PTSD with chronic activation patterns
- Metabolic syndrome and Type 2 Diabetes (cortisol drives Insulin resistance via IRS-1 serine phosphorylation)
- Chronic fatigue syndrome (often shows both high cortisol and receptor resistance)
- Fibromyalgia with HPA axis dysregulation
Metamodel Connections:
- Selfish Brain: Hypercortisolaemia reflects the brain's attempt to monopolize glucose during chronic threat perception, at the expense of peripheral tissues
- Selfish immune system: The immune system's cortisol resistance allows it to maintain inflammatory programs despite central suppression attempts
- Evolutionary mismatch: Chronic psychosocial stressors (job insecurity, social isolation) trigger a system designed for acute physical threats, creating maladaptive persistence
Clinical Thresholds:
- Morning cortisol >20 μg/dL on repeated measures suggests hypercortisolaemia
- Flattened cortisol awakening response (CAR <2.5 nmol/L increase) indicates receptor dysfunction
- Evening cortisol >5 μg/dL (should be
μg/dL) indicates loss of circadian rhythm - 24-hour urinary free cortisol >100 μg/day confirms chronic elevation
Intervention Strategy:
The key insight: lowering cortisol alone (via phosphatidylserine, adaptogens) is insufficient. Must restore receptor sensitivity:
- Address methylation status: 5-MTHF, Methylation support
- Reduce inflammatory drivers blocking GR: Omega-3 fatty acids, Curcumin, Resolvins
- Restore circadian rhythm: light therapy, Melatonin (0.3-1 mg), timed eating
- Support neurogenesis: Exercise, BDNF-promoting interventions
- Psychotherapy to reduce chronic threat perception (CBT, EMDR, Mindfulness)
¶ Key Facts
- Cortisol becomes neurotoxic when GR expression drops below ~50% of baseline (measured via GR mRNA in leukocytes)
- Hippocampal volume loss correlates with cumulative cortisol exposure: ~1-2% volume reduction per year of untreated hypercortisolaemia
- Cortisol resistance in monocytes can be measured via dexamethasone suppression: failure to suppress IL-6 production >50% indicates resistance
- Morning cortisol peaks at 06:00-08:00 (~15-20 μg/dL); hypercortisolaemia shows levels >20 μg/dL that persist throughout the day
- The "cortisol paradox" in depression: 40-60% have high cortisol AND high CRP, indicating simultaneous HPA and immune activation
- Chronic elevation for >6 months associates with 3-fold increased risk of Metabolic syndrome
- Exogenous glucocorticoid therapy (e.g., prednisone >7.5 mg/day for >3 weeks) can induce similar receptor downregulation
- Genetic vulnerability: FKBP5 polymorphisms increase sensitivity to cortisol-induced GR resistance
- Recovery timeline: receptor upregulation takes 3-6 months after cortisol normalization
- Hippocampus CA3 pyramidal neurons are most vulnerable; CA1 shows secondary damage
¶ Connections
- Cortisol — the primary molecule involved; elevated >20 μg/dL chronically
- Glucocorticoid Receptor — downregulation is the core mechanism converting cortisol from protective to toxic
- Cortisol resistance — the immune cell-specific manifestation of GR dysfunction
- HPA axis — chronic activation is the upstream driver of hypercortisolaemia
- Hippocampus — primary target organ for cortisol neurotoxicity; shows measurable atrophy
- hippocampal atrophy — structural consequence visible on MRI; correlates with memory impairment
- BDNF — cortisol suppresses BDNF expression, blocking neurogenesis and synaptic plasticity
- Adult Hippocampal Neurogenesis — severely impaired by chronic high cortisol
- CRH — persistently elevated due to loss of negative feedback
- Depression — hypercortisolaemia found in 40-60% of melancholic depression cases
- Anxiety — sustained cortisol elevations maintain threat-detection circuits in Amygdala
- neuroinflammation — paradoxically increased despite high cortisol when receptors are resistant
- NF-κB — remains active in immune cells despite cortisol presence when GR is downregulated
- IL-6 — elevated (>10 pg/mL) in hypercortisolaemia despite cortisol's intended anti-inflammatory effect
- TNF-α — similarly elevated, indicating immune cortisol resistance
- Insulin resistance — cortisol directly phosphorylates IRS-1 at serine residues, blocking insulin signaling
- Metabolic syndrome — hypercortisolaemia is a major contributor via visceral adiposity and insulin resistance
- Allostasis — hypercortisolaemia represents failed allostasis transitioning to Allostatic load
- Chronic stress — the most common upstream cause in psychoneuroimmunology
- chronic inflammation — the paradoxical result when cortisol loses its anti-inflammatory function
- SOCS3 — upregulated in resistant immune cells, blocks GR signaling via JAK-STAT interference
- Conserved Transcriptional Response to Adversity — the genomic signature of simultaneous HPA and immune activation
- DNA Methylation — mechanism of GR gene silencing; reversible with methylation support
- FKBP5 — genetic variant increases cortisol sensitivity and risk of receptor downregulation
- cognitive decline — result of hippocampal damage from chronic cortisol neurotoxicity
- memory — impaired consolidation and retrieval due to hippocampal dysfunction
- NMDA receptor — overactivated by glutamate during cortisol-induced excitotoxicity
- Glutamate — excessive release is a key neurotoxic mechanism in hypercortisolaemia
- Reactive Oxygen Species — increased production contributes to neuronal oxidative damage
- mitochondrial dysfunction — cortisol excess impairs oxidative phosphorylation in neurons
¶ Module References
- Module 1